Vericiguat's Effects on Acute Coronary Syndrome Patients with Diminished Ejection Fraction: Insights from the EVE-ACSrEF Trial - Top-Institutions - MDSpire

Vericiguat's Effects on Acute Coronary Syndrome Patients with Diminished Ejection Fraction: Insights from the EVE-ACSrEF Trial

  • By

  • Xinying Shi

  • Anran Zhao

  • Yi Ding

  • Lingfeng Gu

  • Tongtong Yang

  • Hao Wang

  • Qiming Wang

  • Sibo Wang

  • Liansheng Wang

  • February 21, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Interventional Cardiology

  • #2

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Clinical Trials

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Vascular Medicine

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Clinical Pharmacology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Translational Medicine

Original Source(s)

Vericiguat's Effects on Acute Coronary Syndrome Patients with Diminished Ejection Fraction: Insights from the EVE-ACSrEF Trial

  • by Xinying Shi, Anran Zhao, Yi Ding, Lingfeng Gu, Tongtong Yang, Hao Wang, Qiming Wang, Sibo Wang, Liansheng Wang

  • February 21, 2026

Related Content

Case Report: Selective metal cell excision during open TAVR implantation preserves coronary access while maintaining valve integrity and function

Corvad as a bridge to LVAD implantation in end-stage heart disease complicated by cardiogenic shock: a three-case series

Abnormal active myocardial relaxation by dipyridamole stress test in suspected early-stage heart failure with preserved ejection fraction: a retrospective exploratory analysis